The role of cross-sectional imaging of the extracranial and intracranial vasculature in embolic stroke of undetermined source
- PMID: 36090870
- PMCID: PMC9459011
- DOI: 10.3389/fneur.2022.982896
The role of cross-sectional imaging of the extracranial and intracranial vasculature in embolic stroke of undetermined source
Abstract
Despite an extensive workup, nearly one third of ischemic strokes are defined as Embolic Stroke of Undetermined Source (ESUS), indicating that no clear etiologic cause has been identified. Since large vessel atherosclerotic disease is a major cause of ischemic stroke, we focus on imaging of large vessel atherosclerosis to identify further sources of potential emboli which may be contributing to ESUS. For a stroke to be considered ESUS, both the extracranial and intracranial vessels must have <50% stenosis. Given the recent paradigm shift in our understanding of the role of plaque vulnerability in ischemic stroke risk, we evaluate the role of imaging specific high-risk extracranial plaque features in non-stenosing plaque and their potential contributions to ESUS. Further, intracranial vessel-wall MR is another potential tool to identify non-stenosing atherosclerotic plaques which may also contribute to ESUS. In this review, we discuss the role of cross-sectional imaging of the extracranial and intracranial arteries and how imaging may potentially uncover high risk plaque features which may be contributing to ischemic strokes.
Keywords: atherosclerosis; carotid artery disease; carotid artery stenosis; cerebrovascular disease/stroke; magnetic resonance angiography.
Copyright © 2022 Baradaran, Kamel and Gupta.
Conflict of interest statement
HK serves as a PI for the NIH-funded ARCADIA trial (NINDS U01NS095869), which receives in-kind study drug from the BMS-Pfizer Alliance for Eliquis® and ancillary study support from Roche Diagnostics; as Deputy Editor for JAMA Neurology; on clinical trial steering/executive committees for Medtronic, Janssen, and Javelin Medical; and on endpoint adjudication committees for AstraZeneca, Novo Nordisk, and Boehringer Ingelheim. He has an ownership interest in TETMedical, Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Vessel wall MR imaging of aortic arch, cervical carotid and intracranial arteries in patients with embolic stroke of undetermined source: A narrative review.Front Neurol. 2022 Jul 28;13:968390. doi: 10.3389/fneur.2022.968390. eCollection 2022. Front Neurol. 2022. PMID: 35968273 Free PMC article. Review.
-
Atherosclerosis as a Potential Cause of Deep Embolic Stroke of Undetermined Source: A 3T High-Resolution Magnetic Resonance Imaging Study.J Am Heart Assoc. 2022 Nov;11(21):e026737. doi: 10.1161/JAHA.122.026737. Epub 2022 Oct 27. J Am Heart Assoc. 2022. PMID: 36300665 Free PMC article.
-
Prevalence of Ipsilateral Nonstenotic Carotid Plaques on Computed Tomography Angiography in Embolic Stroke of Undetermined Source.Stroke. 2020 Jun;51(6):1743-1749. doi: 10.1161/STROKEAHA.120.029404. Epub 2020 May 7. Stroke. 2020. PMID: 32375585 Clinical Trial.
-
The role of non-stenosing carotid artery plaques in embolic stroke of undetermined source, is it a silent offender? A review of literature.Interv Neuroradiol. 2024 Oct;30(5):759-767. doi: 10.1177/15910199221143172. Epub 2022 Nov 30. Interv Neuroradiol. 2024. PMID: 36451548 Free PMC article. Review.
-
Prevalence of ipsilateral "vulnerable carotid plaques with <50 % stenosis" on CT angiography in embolic stroke of undetermined source.J Neurol Sci. 2024 Dec 15;467:123316. doi: 10.1016/j.jns.2024.123316. Epub 2024 Nov 20. J Neurol Sci. 2024. PMID: 39580929 Clinical Trial.
Cited by
-
Prevalence of non-stenotic vulnerable carotid plaques in embolic stroke of undetermined source.Neurol Sci. 2025 Jan;46(1):239-247. doi: 10.1007/s10072-024-07744-w. Epub 2024 Aug 23. Neurol Sci. 2025. PMID: 39174770
-
The Role of High-Resolution Magnetic Resonance Imaging in Cerebrovascular Disease: A Narrative Review.Brain Sci. 2023 Apr 18;13(4):677. doi: 10.3390/brainsci13040677. Brain Sci. 2023. PMID: 37190642 Free PMC article. Review.
-
Neovascularization in Atherosclerotic Plaques: Clinical Implications, Detection, and Prevention Strategies.Rev Cardiovasc Med. 2025 Jul 23;26(7):36468. doi: 10.31083/RCM36468. eCollection 2025 Jul. Rev Cardiovasc Med. 2025. PMID: 40776974 Free PMC article. Review.
-
Study on the association between neovascularization of culprit lesions and plaque rupture in patients with acute myocardial infarction.BMC Cardiovasc Disord. 2025 Aug 2;25(1):567. doi: 10.1186/s12872-025-04995-z. BMC Cardiovasc Disord. 2025. PMID: 40753374 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources